home / stock / adil / adil news


ADIL News and Press, Adial Pharmaceuticals Inc From 10/24/23

Stock Information

Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com

Menu

ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...

ADIL - Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CHARLOTTESVILLE, Va., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,...

ADIL - AUMN, UUU and MTC among mid-day movers

2023-10-20 13:19:49 ET Gainers: Lipella Pharmaceuticals ( LIPO ) +46% . Nouveau Monde Graphite ( NMG ) +43% . Golden Minerals Co ( AUMN ) +38% . Universal Security Instruments ( UUU ) +33% . Sagimet Biosciences ( SGMT ) +23% . ...

ADIL - Adial Pharmaceuticals stock plummets on selling 1.42M shares at $2.82 in private placement

2023-10-20 11:00:13 ET More on Adial Pharmaceuticals Adial Pharmaceuticals reports Q2 results Adial Pharmaceuticals announces reverse stock split to regain compliance Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Ad...

ADIL - Palatin Technologies, Protalix BioTherapeutics, Arcutis among healthcare movers

2023-10-20 10:06:59 ET More on Health Care: Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the...

ADIL - Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CHARLOTTESVILLE, Va., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,...

ADIL - Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th

CHARLOTTESVILLE, VA / ACCESSWIRE / October 19, 2023 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it wi...

ADIL - Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence

CHARLOTTESVILLE, Va., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award

CHARLOTTESVILLE, Va., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related diso...

ADIL - Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder

Pre-registration for the LinkedIn Live event will begin on Thursday, September 28th Industry experts to discuss the need for non-abstinence-based therapies in Alcohol Use Disorder (AUD) CHARLOTTESVILLE, Va., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:...

ADIL - Purple Biotech, Allakos among healthcare movers

2023-09-27 09:59:57 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...

Previous 10 Next 10